290
Views
0
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

A Hospital-Based and Cross-Sectional Investigation on Clinical Characteristics of Pediatric Streptococcus pneumoniae Isolates in Beijing from 2015 to 2021

, , , , , , , & show all
Pages 499-508 | Received 30 Nov 2022, Accepted 14 Jan 2023, Published online: 26 Jan 2023

References

  • World Health Organization. Pneumococcal vaccines WHO position paper--2012. Wkly Epidemiol Rec. 2012;87(14):129–144.
  • Yildirim I, Shea KM, Pelton SI. Pneumococcal disease in the era of pneumococcal conjugate vaccine. Infect Dis Clin North Am. 2015;29(4):679–697. doi:10.1016/j.idc.2015.07.009
  • Choe YJ, Choi EH, Lee HJ. The changing epidemiology of childhood pneumococcal disease in Korea. Infect Chemother. 2013;45(2):145–158. doi:10.3947/ic.2013.45.2.145
  • Amin AN, Cerceo EA, Deitelzweig SB, Pile JC, Rosenberg DJ, Sherman BM. The hospitalist perspective on treatment of community-acquired bacterial pneumonia. Postgrad Med. 2014;126(2):18–29. doi:10.3810/pgm.2014.03.2737
  • Mendes C, Marin ME, Quinones F, et al. Antibacterial resistance of community-acquired respiratory tract pathogens recovered from patients in Latin America: results from the PROTEKT surveillance study (1999–2000). Braz J Infect Dis. 2003;7(1):44–61. doi:10.1590/S1413-86702003000100006
  • Hsueh PR, Luh KT. Antimicrobial resistance in Streptococcus pneumoniae, Taiwan. Emerg Infect Dis. 2002;8(12):1487–1491. doi:10.3201/eid0812.020178
  • Oligbu G, Fry NK, Ladhani SN. The Pneumococcus and Its Critical Role in Public Health. Methods Mol Biol. 2019;1968:205–213.
  • Fu P, Xu H, Jing C, et al. Bacterial epidemiology and antimicrobial resistance profiles in children reported by the ISPED program in China, 2016 to 2020. Microbiol Spectr. 2021;9(3):e0028321. doi:10.1128/Spectrum.00283-21
  • Li ZJ, Zhang HY, Ren LL, et al. Etiological and epidemiological features of acute respiratory infections in China. Nat Commun. 2021;12(1):5026. doi:10.1038/s41467-021-25120-6
  • Kim JS, Jung BK, Kim JW, Kim GY. Prevalence and antimicrobial susceptibility of streptococcus pneumoniae isolated from clinical samples in the past 8 years in Korea. Biomed Res Int. 2021;2021:6615334. doi:10.1155/2021/6615334
  • Morris MC, Pichichero ME. Streptococcus pneumoniae burden and nasopharyngeal inflammation during acute otitis media. Innate Immun. 2017;23(8):667–677. doi:10.1177/1753425917737825
  • Casey JR, Kaur R, Friedel VC, Pichichero ME. Acute otitis media otopathogens during 2008 to 2010 in Rochester, New York. Pediatr Infect Dis J. 2013;32(8):805–809. doi:10.1097/INF.0b013e31828d9acc
  • Chandrasekharan S, Amin T, Kim J, et al. Intellectual property rights and challenges for development of affordable human papillomavirus, rotavirus and pneumococcal vaccines: patent landscaping and perspectives of developing country vaccine manufacturers. Vaccine. 2015;33(46):6366–6370. doi:10.1016/j.vaccine.2015.08.063
  • Wang CY, Chen YH, Fang C, et al. Antibiotic resistance profiles and multidrug resistance patterns of Streptococcus pneumoniae in pediatrics: a multicenter retrospective study in mainland China. Medicine. 2019;98(24):e15942. doi:10.1097/MD.0000000000015942
  • Smith DK, Kuckel DP, Recidoro AM. Community-acquired pneumonia in children: rapid evidence review. Am Fam Physician. 2021;104(6):618–625.
  • Jiang M, Wang X, Zhu L, et al. Clinical characteristics, antimicrobial resistance, and risk factors for mortality in paediatric invasive pneumococcal disease in Beijing, 2012–2017. BMC Infect Dis. 2022;22(1):338. doi:10.1186/s12879-022-07179-8
  • Song JY, Lee JS, Wie SH, et al. Prospective cohort study on the effectiveness of influenza and pneumococcal vaccines in preventing pneumonia development and hospitalization. Clin Vaccine Immunol. 2015;22(2):229–234. doi:10.1128/CVI.00673-14
  • von Specht M, Garcia Gabarrot G, Mollerach M, et al. Resistance to beta-lactams in Streptococcus pneumoniae. Rev Argent Microbiol. 2021;53(3):266–271. doi:10.1016/j.ram.2021.02.007
  • Jacobs MR. Clinical significance of antimicrobial resistance in Streptococcus pneumoniae. S Afr Med J. 2007;97(11 Pt 3):1133–1140.
  • Sader HS, Mendes RE, Le J, Denys G, Flamm RK, Jones RN. Antimicrobial susceptibility of Streptococcus pneumoniae from North America, Europe, Latin America, and the Asia-Pacific Region: results From 20 Years of the SENTRY Antimicrobial Surveillance Program (1997–2016). Open Forum Infect Dis. 2019;6(Suppl 1):S14–S23. doi:10.1093/ofid/ofy263
  • Yu S, Yao K, Shen X, Zhang W, Liu X, Yang Y. Serogroup distribution and antimicrobial resistance of nasopharyngeal isolates of Streptococcus pneumoniae among Beijing children with upper respiratory infections (2000–2005). Eur J Clin Microbiol Infect Dis. 2008;27(8):649–655. doi:10.1007/s10096-008-0481-y
  • Yao KH, Wang LB, Zhao GM, et al. Surveillance of antibiotic resistance of Streptococcus pneumoniae isolated from hospitalized patients with pneumonia in four children’s hospitals in China [in Chinese]. Chin J Contemp Pediatr. 2008;10(3):275–279.
  • Linares J, Ardanuy C, Pallares R, Fenoll A. Changes in antimicrobial resistance, serotypes and genotypes in Streptococcus pneumoniae over a 30-year period. Clin Microbiol Infect. 2010;16(5):402–410. doi:10.1111/j.1469-0691.2010.03182.x
  • Martin-Loeches I, Rodriguez AH, Torres A. New guidelines for hospital-acquired pneumonia/ventilator-associated pneumonia: USA vs. Europe Curr Opin Crit Care. 2018;24(5):347–352. doi:10.1097/MCC.0000000000000535
  • System CA. 2014至2017年中国儿童及新生儿患者细菌耐药监测研究 [Surveillance of bacterial resistance in children and newborns across China from 2014 to 2017]. Zhonghua Yi Xue Za Zhi. 2018;98(40):3279–3287. Chinese. doi:10.3760/cma.j.issn.0376-2491.2018.40.013
  • Zhao C, Yang S, Zhang F, et al. Antimicrobial resistance trends of the most common causative pathogens associated with community-acquired respiratory infections in China: 2009–2018. Infect Drug Resist. 2022;15:5069–5083. doi:10.2147/IDR.S374805
  • Tsuzuki S, Akiyama T, Matsunaga N, et al. Improved penicillin susceptibility of Streptococcus pneumoniae and increased penicillin consumption in Japan, 2013–2018. PLoS One. 2020;15(10):e0240655. doi:10.1371/journal.pone.0240655
  • Jones RN, Sader HS, Mendes RE, Flamm RK. Update on antimicrobial susceptibility trends among Streptococcus pneumoniae in the United States: report of ceftaroline activity from the SENTRY Antimicrobial Surveillance Program (1998–2011). Diagn Microbiol Infect Dis. 2013;75(1):107–109. doi:10.1016/j.diagmicrobio.2012.08.024
  • Sharew B, Moges F, Yismaw G, et al. Antimicrobial resistance profile and multidrug resistance patterns of Streptococcus pneumoniae isolates from patients suspected of pneumococcal infections in Ethiopia. Ann Clin Microbiol Antimicrob. 2021;20(1):26. doi:10.1186/s12941-021-00432-z
  • Wierzbowski AK, Karlowsky JA, Adam HJ, Nichol KA, Hoban DJ, Zhanel GG. Evolution and molecular characterization of macrolide-resistant Streptococcus pneumoniae in Canada between 1998 and 2008. J Antimicrob Chemother. 2014;69(1):59–66. doi:10.1093/jac/dkt332
  • Aspa J, Rajas O, de Castro FR. Pneumococcal antimicrobial resistance: therapeutic strategy and management in community-acquired pneumonia. Expert Opin Pharmacother. 2008;9(2):229–241. doi:10.1517/14656566.9.2.229
  • Lee HY, Wu TL, Su LH, et al. Invasive pneumococcal disease caused by ceftriaxone-resistant Streptococcus pneumoniae in Taiwan. J Microbiol Immunol Infect. 2018;51(4):500–509. doi:10.1016/j.jmii.2016.12.004
  • Lee MC, Kuo KC, Lee CH, et al. The antimicrobial susceptibility in adult invasive pneumococcal disease in the era of pneumococcus vaccination: a hospital-based observational study in Taiwan. J Microbiol Immunol Infect. 2020;53(6):836–844. doi:10.1016/j.jmii.2020.01.003
  • Cherazard R, Epstein M, Doan TL, Salim T, Bharti S, Smith MA. Antimicrobial resistant streptococcus pneumoniae: prevalence, mechanisms, and clinical implications. Am J Ther. 2017;24(3):e361–e9. doi:10.1097/MJT.0000000000000551
  • Tsai YT, Lee YL, Lu MC, et al. Nationwide surveillance of antimicrobial resistance in invasive isolates of Streptococcus pneumoniae in Taiwan from 2017 to 2019. J Microbiol Immunol Infect. 2021;55(2):215–224.
  • Choi SH, Park SJ, Jun JB, et al. Comparative in vitro activities of carbapenem antimicrobial agents against 264 penicillin-resistant Streptococcus pneumoniae isolates from Korea. Diagn Microbiol Infect Dis. 2007;58(1):141–143. doi:10.1016/j.diagmicrobio.2006.11.017
  • Tzouvelekis LS, Markogiannakis A, Psichogiou M, Tassios PT, Daikos GL. Carbapenemases in Klebsiella pneumoniae and other Enterobacteriaceae: an evolving crisis of global dimensions. Clin Microbiol Rev. 2012;25(4):682–707. doi:10.1128/CMR.05035-11
  • Nakano S, Fujisawa T, Ito Y, et al. Penicillin-binding protein typing, antibiotic resistance gene identification, and molecular phylogenetic analysis of meropenem-resistant Streptococcus pneumoniae serotype 19A-CC3111 Strains in Japan. Antimicrob Agents Chemother. 2019;63:9. doi:10.1128/AAC.00711-19
  • Kim SH, Song JH, Chung DR, et al. Changing trends in antimicrobial resistance and serotypes of Streptococcus pneumoniae isolates in Asian countries: an Asian Network for Surveillance of Resistant Pathogens (ANSORP) study. Antimicrob Agents Chemother. 2012;56(3):1418–1426. doi:10.1128/AAC.05658-11
  • Shi W, Li J, Dong F, et al. Serotype distribution, antibiotic resistance pattern, and multilocus sequence types of invasive Streptococcus pneumoniae isolates in two tertiary pediatric hospitals in Beijing prior to PCV13 availability. Expert Rev Vaccines. 2019;18(1):89–94. doi:10.1080/14760584.2019.1557523